High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response-Reference-Cited by-同舟云学术

High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response

Published:2024-02-10 Issue:3 Volume:102 Page:415-433
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Pan Jiajia,Wang Yungui,Huang Shujuan,Mao Shihui,Ling Qing,Li Chenying,Li Fenglin,Yu Mengxia,Huang Xin,Huang Jiansong,Lv Yunfei,Li Xia,Ye Wenle,Wang Huafeng,Wang Jinghan,Jin Jie^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00109-023-02409-1.pdf

Reference43 articles.

1. Cerrano M, Itzykson R (2019) New treatment options for acute myeloid leukemia in 2019. Curr Oncol Rep 21(2):16

2. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115(3):453–474

3. Wang Y, Zhang L, Chen WL, Wang JH, Li N, Li JM et al (2013) Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis. J Proteome Res 12(10):4393–4401

4. Castro I, Sampaio-Marques B, Ludovico P (2019) Targeting metabolic reprogramming in acute myeloid leukemia. Cells 8(9)

5. Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM et al (2013) BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med 19(7):901–908

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia;Frontiers in Pharmacology;2024-08-08